Tag: Immunic Inc.

Insiders Updates

Leerink Partners gives an Outperform recommendation for Immunic Inc (IMUX)

Immunic Inc’s filing revealed that its Director Rudick Richard Alan acquired Company’s shares for reported $0.1 million on Nov 12

Analysts Viewpoint

A Guide To The Risks Of Investing In Immunic Inc (IMUX)

Taking this into account, A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to

Immunic Inc. (NASDAQ: IMUX) Trading under Its 20 Day MA ($2.20), Why Showing An Interesting Price Pattern?

Immunic Inc. (NASDAQ:IMUX) does about 1.05M shares in volume on a normal day but saw 679992 shares change hands in